We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App





BD Presents Preanalytical Specimen Management Solutions

By LabMedica International staff writers
Posted on 28 Jul 2026

BD is highlighting preanalytical specimen management technologies and support services at ADLM 2026, held July 26–30 in Anaheim, California. More...

At booth 2035, visitors can explore solutions designed to improve specimen quality and support evolving laboratory collection and processing needs.

The company’s exhibit focuses on preanalytical solutions for venous blood collection, urine collection, and blood gas analysis. These offerings are intended to help laboratories manage the critical steps that occur before testing and reduce variables that can affect the quality and reliability of diagnostic results.

BD is also presenting cell and biomarker preservation products intended to protect specimens between collection and analysis. Live demonstrations of the BD Learning Academy show how laboratories and healthcare professionals can access training resources, while an interactive station examines the future of specimen collection.

As part of its ADLM participation, BD is sponsoring the symposium “Quality in, Clarity Out: Improving Urine Culture Performance Through Multidisciplinary Interventions” on July 28 from 3:30 p.m. to 4:30 p.m. in Theater 3. The session examines a phased, multi-hospital study of strategies to reduce urine culture contamination, improve test quality, and support diagnostic stewardship.

The presentation also explores collaboration among clinical laboratories, frontline care teams, and industry partners. Data from the BD HealthSight MedMined database are used to evaluate outcomes before and after the interventions across multiple hospitals, including changes in antimicrobial use and Clostridioides difficile infection rates.

BD is additionally presenting two posters on July 28. One evaluates the within-tube stability of BD Vacutainer Rapid Serum Tubes for selected chemistry analytes and cardiac markers, while the second reviews urinalysis reflex-to-culture strategies and their impact on urine culture diagnostic stewardship and clinical outcomes.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Thyroid Test
Anti-Thyroid EIA Test
Prefilled Tubes
Prefilled 5.0ml Tubes
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: New findings demonstrate that anti-Müllerian hormone (AMH) may help identify which breast cancer patients are most likely to benefit from chemotherapy plus endocrine therapy (Image Credit: Shutterstock)

AMH Test Helps Predict Adjuvant Chemotherapy Benefit in Premenopausal Breast Cancer

Hormone receptor-positive, human epidermal growth factor receptor 2-negative (HR+/HER2-) breast cancer can present a difficult treatment decision in premenopausal patients with low recurrence scores.... Read more

Molecular Diagnostics

view channel
Image Credit: iStock

Sequencing-Based Newborn Screening Identifies Pediatric Cancer Risk at Birth

Newborn screening in the United States relies on heel-stick blood spots to identify rare, treatable disorders through biochemical testing, but these programs generally do not assess inherited cancer risk... Read more

Microbiology

view channel
Image: The QIAstat-Dx BCID GPF Plus AMR Panel is the first QIAstat-Dx panel for bloodstream infections to receive FDA clearance (Photo courtesy of Qiagen)

FDA Clears One-Hour Panel for Bloodstream Infection and AMR Detection

Bloodstream infections can rapidly progress to sepsis, a life-threatening condition affecting an estimated 1.7 million adults in the U.S. each year. Rapid identification of pathogens and antimicrobial... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.